ArticleMenopause (New York, N.Y.)2020

A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study.

Ekta Kapoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.